Health Times of Rhode Island: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Times of Rhode Island.

Press releases published on August 4, 2026

Aug. 4, 2026

Integrity Urgent Care Clinic Opens in Murphy, Texas

Indeterminate GlobeNewswire

Aug. 4, 2026

Integrity Urgent Care Clinic Opens in Conroe, Texas

Indeterminate GlobeNewswire

Aug. 4, 2026

Akari Therapeutics Releases CEO Corner Highlighting Strategic WhiteHawk Collaboration and the Expanding Opportunity for Dual-Payload ADC Innovation

Indeterminate GlobeNewswire

Aug. 4, 2026

Allogene Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update

Indeterminate GlobeNewswire

Aug. 4, 2026

Wave Life Sciences to Present at Upcoming Investor Conferences

Indeterminate GlobeNewswire

Aug. 4, 2026

Veru Announces Notice of Allowance for Key Methods of Use U.S. Patent for Enobosarm in Combination with Semaglutide for Quality Weight Loss

Indeterminate GlobeNewswire

Aug. 4, 2026

Sofwave Medical Reports Second Quarter and First Half 2026 Financial Results and Business Highlights

Indeterminate GlobeNewswire

Aug. 4, 2026

Bicara Therapeutics to Report Second Quarter 2026 Financial Results and Business Updates on August 11, 2026, at 8:30 AM ET

Indeterminate GlobeNewswire

Aug. 4, 2026

RenovoRx to Highlight TAMP™ Platform at JonesTrading Virtual Key Opinion Leader Webinar on the Evolving Pancreatic Cancer Landscape, August 13th

Indeterminate GlobeNewswire

Aug. 4, 2026

Entera Bio Phase 2 Data Supporting EB613’s (Oral PTH(1-34)) Anabolic Effect on Postmenopausal Women with Osteoporosis at High Risk for Fracture Selected for Plenary Poster Session Presentation at the ASBMR 2026 Annual Meeting

Indeterminate GlobeNewswire

Aug. 4, 2026

Milestone Scientific Announces Strategic Federal Distribution Partnership with Red One Medical to Expand Commercial Access for the CompuFlo® Epidural System

Indeterminate GlobeNewswire

Aug. 4, 2026

Carbonium Core Reports Rare Earth and Critical Mineral Content in Initial Sample Assay

Indeterminate GlobeNewswire

Aug. 4, 2026

Corbus Pharmaceuticals Announces Last Patient Last Visit in CANYON-1 Study of CRB-913 for the Treatment of Obesity

Indeterminate GlobeNewswire

Aug. 4, 2026

Beacon Behavioral Partners Expands National Footprint with First Georgia Partnership

Indeterminate GlobeNewswire

Aug. 4, 2026

Clinical Nutrition Market to Reach $104.7 Billion by 2031, Driven by Aging Demographics and Rising Chronic Disease Burden

Indeterminate GlobeNewswire

Aug. 4, 2026

Autonomix Medical Expands Precision Neuromodulation Platform with Broad New U.S. Patent Supporting Nerve Sensing, Mapping and Targeted Therapy

Indeterminate GlobeNewswire

Aug. 4, 2026

ABLi Therapeutics Announces Outcomes from its Parkinson’s-related Biomarker Study Demonstrating Modification of Human Disease with Risvodetinib

Indeterminate GlobeNewswire

Aug. 4, 2026

IMUNON to Hold Second Quarter 2026 Financial Results and Business Update Conference Call on Tuesday, August 11, 2026

Indeterminate GlobeNewswire

Aug. 4, 2026

Mineralys Therapeutics to Announce Second Quarter 2026 Financial Results and Host Conference Call on Tuesday, August 11, 2026

Indeterminate GlobeNewswire

Aug. 4, 2026

FDA clears Healis Therapeutics’ IND for Tyemvers®, Enabling U.S. Neuropsychiatric Trials

Indeterminate GlobeNewswire